Publications by authors named "B Giribaldi"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

900,045

Total Likes

16,803

Extended Reach

1,200,884

Social Features

46
P
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
R L Carhart-Harris, M Bolstridge, C M J Day, J Rucker, R Watts, D E Erritzoe, M Kaelen, B Giribaldi, M Bloomfield, S Pilling

February 2018

Videos about Article: user user user 3

6 4 40 16 70

View All Article and Social Media Activity
T
Thresholding and Perfusion Considerations in Interpreting Reduced Brain Responsiveness With Escitalopram: Response to Knudsen et al.
Matthew B Wall, Lysia Demetriou, Bruna Giribaldi, Leor Roseman, Natalie Ertl

Am J Psychiatry· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.
Jessica Henry, Bruna Giribaldi, David J Nutt, David Erritzoe, Robin Carhart-Harris

Eur Neuropsychopharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.
Matthew B Wall, Lysia Demetriou, Bruna Giribaldi, Leor Roseman, Natalie Ertl

Am J Psychiatry· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.
William Roseby, Hannes Kettner, Leor Roseman, Meg J Spriggs, Taylor Lyons, Bruna Giribaldi

Front Psychol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
David Erritzoe, Tommaso Barba, Kyle T Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi

EClinicalMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis